Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons

被引:81
作者
Akerman, Simon
Holland, Philip R.
Goadsby, Peter J.
机构
[1] Inst Neurol, Headache Grp, London WC1N 3BG, England
[2] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
关键词
D O I
10.1124/jpet.106.106971
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Migraine is a common and disabling neurological disorder that involves activation or the perception of activation of the trigeminovascular system. Cannabinoid ( CB) receptors are present in brain and have been suggested to be antinociceptive. Here we determined the effect of cannabinoid receptor activation on neurons with trigeminovascular nociceptive input in the rat. Neurons in the trigeminocervical complex (TCC) were studied using extracellular electrophysiological techniques. Responses to both dural electrical stimulation and cutaneous facial receptive field activation of the ophthalmic division of the trigeminal nerve and the effect of cannabinoid agonists and antagonists were studied. Nonselective CB receptor activation with R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazin-yl]-(1-naphthalenyl) (WIN55,212; 1 mg kg(-1)) inhibited neuronal responses to A- (by 52%) and C-fiber (by 44%) afferents, an effect blocked by the CB1 receptor antagonist SR141716 [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide; 3 mg kg(-1)] but not the CB2 receptor antagonist AM630 (6-iodopravadoline; 3 mg kg(-1)). Anandamide (10 mg kg(-1)) was able to inhibit both A- and C-fiber-elicited TCC firing, only after transient receptor potential vanilloid 1 receptor inhibition. Activation of cannabinoid receptors had no effect on cutaneous receptive fields when recorded from TCC neurons. The data show that manipulation of CB1 receptors can affect the responses of trigeminal neurons with A- and C-fiber inputs from the dura mater. This may be a direct effect on neurons in the TCC itself or an effect in discrete areas of the brain that innervate these neurons. The data suggest that CB receptors may have therapeutic potential in migraine, cluster headache, or other primary headaches, although the potential hazards of psychoactive side effects that accompany cannabinoid treatments may be complex to overcome.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 41 条
[1]  
ADAMS IB, 1995, J PHARMACOL EXP THER, V273, P1172
[2]   Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors [J].
Akerman, S ;
Kaube, H ;
Goadsby, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (08) :1354-1360
[3]   Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception [J].
Akerman, S ;
Kaube, H ;
Goadsby, PJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :56-63
[4]   Cost of disorders of the brain in Europe [J].
Andlin-Sobocki, P ;
Jönsson, B ;
Wittchen, HU ;
Olesen, J .
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 :1-+
[5]   Activation of 5-HT1B/1D receptor in the periaqueductal gray inhibits nociception [J].
Bartsch, T ;
Knight, YE ;
Goadsby, PJ .
ANNALS OF NEUROLOGY, 2004, 56 (03) :371-381
[6]   Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat [J].
Bereiter, DA ;
Bereiter, DF ;
Hirata, H .
PAIN, 2002, 99 (03) :547-556
[7]   ANANDAMIDE, AN ENDOGENOUS LIGAND OF THE CANNABINOID RECEPTOR, INDUCES HYPOMOTILITY AND HYPOTHERMIA IN-VIVO IN RODENTS [J].
CRAWLEY, JN ;
CORWIN, RL ;
ROBINSON, JK ;
FELDER, CC ;
DEVANE, WA ;
AXELROD, J .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (04) :967-972
[8]   The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats [J].
Cumberbatch, MJ ;
Hill, RG ;
Hargreaves, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 362 (01) :43-46
[9]   Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs [J].
Cupini, LM ;
Bari, M ;
Battista, N ;
Argirò, G ;
Finazzi-Agrò, A ;
Calabresi, P ;
Maccarrone, M .
CEPHALALGIA, 2006, 26 (03) :277-281
[10]   Are cannabis-based chemicals helpful in headache? [J].
Evans, RW ;
Ramadan, NM .
HEADACHE, 2004, 44 (07) :726-727